PepGen (PEPG) Liabilities and Shareholders Equity (2021 - 2026)

PepGen (PEPG) reported Liabilities and Shareholders Equity of $156.3 million for Q1 2026, up 22.69% on a YoY basis from $127.4 million in Q1 2025, and down 10.13% sequentially from $173.9 million in Q4 2025.

PepGen (PEPG) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $156.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 22.69% year-over-year to $156.3 million; the trailing twelve-month figure through Mar 2026 stood at $622.5 million (down 3.04% YoY), and the FY2025 full-year result was $173.9 million, up 15.26% from the prior year.
  • Liabilities and Shareholders Equity slipped to $156.3 million in Q1 2026, from $173.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $230.8 million in Q2 2022 to a low of $102.2 million in Q2 2025.
  • A 5-year average of $173.6 million and a median of $173.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity surged 52.44% in 2023 and sank 47.16% in 2025, its largest moves.
  • Tracing PEPG's Liabilities and Shareholders Equity over 5 years: stood at $217.4 million in 2022, then tumbled by 34.21% to $143.1 million in 2023, then grew by 5.47% to $150.9 million in 2024, then increased by 15.26% to $173.9 million in 2025, then declined by 10.13% to $156.3 million in 2026.
  • Business Quant data shows PEPG's Liabilities and Shareholders Equity at $156.3 million in Q1 2026, $173.9 million in Q4 2025, and $190.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 PepGen 145.09 Mn 145.09 Mn - 156.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 156.30 Mn
Dec 31, 2025 173.91 Mn
Sep 30, 2025 190.06 Mn
Jun 30, 2025 102.24 Mn
Mar 31, 2025 127.39 Mn
Dec 31, 2024 150.88 Mn
Sep 30, 2024 170.23 Mn
Jun 30, 2024 193.51 Mn
Mar 31, 2024 207.00 Mn
Dec 31, 2023 143.05 Mn
Sep 30, 2023 164.27 Mn
Jun 30, 2023 182.09 Mn
Mar 31, 2023 201.04 Mn
Dec 31, 2022 217.44 Mn
Sep 30, 2022 208.46 Mn
Jun 30, 2022 230.80 Mn
Mar 31, 2022 131.88 Mn
Dec 31, 2021 143.64 Mn